MECHANISMS OF IMMUNOLOGIC TOLERANCE AND ITS BREAKDOWN
MECHANISMS OF IMMUNOLOGIC TOLERANCE AND ITS BREAKDOWN
批准号:
6076550
负责人:
David William Scott
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-03-01 至 2001-02-28
中文摘要
描述(改编自申请人的申请):建立
免疫耐受是免疫学的基本原理之一,
最活跃的研究领域。了解自我的机制
耐受性的非自我辨别及其在自身免疫中的破坏,
开发免疫性疾病治疗新疗法的前沿
疾病,如糖尿病、狼疮和多发性硬化症。目前,
耐受性的转基因模型,使用具有重排的T细胞和B细胞的小鼠
受体和表达肽或抗原,
启动子,为耐受机制提供了新的见解。审查
宽容的命运(例如,无反应性)细胞也被
这类模式的推动。此外,这些模型,以及使用
克隆的T和B细胞系或淋巴瘤,提供了令人兴奋的方法,
了解免疫系统中无反应性与凋亡的信号。
本次会议将讨论免疫耐受的机制及其
自身免疫的崩溃,以及新的疗法,通过促进
基础和临床研究人员在不同领域的互动。将具有
生物技术科学家以及博士后研究员也对此非常感兴趣。
英文摘要
DESCRIPTION (adapted from the applicant s application): The establishment of
immunologic tolerance is one of the fundamental tenets of immunology and one
of the most active areas of research. Understanding the mechanisms of self-
nonself discrimination in tolerance and its breakdown in autoimmunity are at
the cutting edge for developing new therapies in the treatment of immunologic
diseases, such as diabetes, lupus and multiple sclerosis. Currently,
transgenic models for tolerance, using mice with rearranged T- and B-cell
receptors and expressing peptides or antigens under the control of different
promoters, provide novel insights into tolerance mechanisms. Examination of
the fate of tolerant (e.g., anergic) cells in the periphery has also been
facilitated by such models. Moreover, these models, as well as the use of
cloned T- and B-cell lines or lymphomas, are providing exciting approaches to
understanding the signals for anergy versus apoptosis in the immune system.
This meeting will address the mechanisms of immunologic tolerance and its
breakdown in autoimmunity, as well as novel therapies, by promoting the
interaction of basic and clinical researchers in diverse fields. It will be of
great interest also to biotech scientists, as well as post-doctoral fellows.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bispecific antibody to target FVIII-specific B cells
-
批准号:10598041
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2022
-
负责人:David William Scott
-
依托单位:
Bispecific antibody to target FVIII-specific B cells
-
批准号:10365461
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2022
-
负责人:David William Scott
-
依托单位:
Engineering Specific Regulatory T Cells to Treat Allergy
-
批准号:9979502
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2020
-
负责人:David William Scott
-
依托单位:
Engineered CARs Targeting FVIII-specific T and B Cells
-
批准号:9034735
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2016
-
负责人:David William Scott
-
依托单位:
Engineered CARs Targeting FVIII-specific T and B Cells
-
批准号:9258469
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2016
-
负责人:David William Scott
-
依托单位:
Induction of Tolerance to FVIII in Hemophilia
-
批准号:9260046
-
项目类别:
-
资助金额:$47.33万
-
财政年份:2015
-
负责人:David William Scott
-
依托单位:
Induction of Tolerance to FVIII in Hemophilia
-
批准号:9064200
-
项目类别:
-
资助金额:$38.95万
-
财政年份:2015
-
负责人:David William Scott
-
依托单位:
Induction of Tolerance to FVIII in Hemophilia
-
批准号:8858194
-
项目类别:
-
资助金额:$38.95万
-
财政年份:2015
-
负责人:David William Scott
-
依托单位:
Anitgen specific human T regulatory cell suppression of CCR6 positive Th17 cells
-
批准号:9200215
-
项目类别:
-
资助金额:$8.39万
-
财政年份:2015
-
负责人:David William Scott
-
依托单位:
Gene Therapeutic Approach for Tolerance Induction
-
批准号:7922278
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2009
-
负责人:David William Scott
-
依托单位:
Mechanism of B-cell Delivered Tolerance in Diabetes
-
批准号:7369887
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2006
-
负责人:David William Scott
-
依托单位:
Mechanism of B-cell Delivered Tolerance in Diabetes
-
批准号:7188580
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2006
-
负责人:David William Scott
-
依托单位:
Mechanism of B-cell Delivered Tolerance in Diabetes
-
批准号:7048116
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2006
-
负责人:David William Scott
-
依托单位:
Novel Methods for B-cell Delivery of Tolerogenic Epitop*
-
批准号:6781528
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2004
-
负责人:David William Scott
-
依托单位:
Novel Methods for B-cell Delivery of Tolerogenic Epitop*
-
批准号:6887790
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2004
-
负责人:David William Scott
-
依托单位:
Mechanisms of Immunologic Tolerance and Its Breakdown
-
批准号:6559704
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2003
-
负责人:David William Scott
-
依托单位:
Designing IgG Constructs for Tolerance to Diabetogenic *
-
批准号:6352498
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2001
-
负责人:David William Scott
-
依托单位:
Designing IgG Constructs for Tolerance to Diabetogenic *
-
批准号:6617973
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2001
-
负责人:David William Scott
-
依托单位:
Designing IgG Constructs for Tolerance to Diabetogenic *
-
批准号:6933752
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2001
-
负责人:David William Scott
-
依托单位:
Designing IgG Constructs for Tolerance to Diabetogenic *
-
批准号:6525212
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2001
-
负责人:David William Scott
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: